Skip to main content

letter

. 1996 May 11;312(7040):1225–1226. doi: 10.1136/bmj.312.7040.1225b

Developing a policy on osteoporosis. Bone densitometry is worth while.

PMCID: PMC2350971 PMID: 8634577

1225

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Johannesson M. The cost-effectiveness of the switch towards more expensive antihypertensive drugs. Health Policy. 1994 Mar;28(1):1–13. doi: 10.1016/0168-8510(94)90016-7. [DOI] [PubMed] [Google Scholar]
Sheldon T. A., Raffle A., Watt I. Department of Health shoots itself in the hip. Why the report of the Advisory Group on Osteoporosis undermines evidence based purchasing. BMJ. 1996 Feb 3;312(7026):296–297. doi: 10.1136/bmj.312.7026.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
Torgerson D. J., Donaldson C., Russell I. T., Reid D. M. Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol Reprod Biol. 1995 Mar;59(1):57–60. doi: 10.1016/0028-2243(94)02002-v. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES